Relay Therapeutics Announces $30 Million Private Placement Financing
CAMBRIDGE, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that it has entered into a securities purchase agreement for a private placement financing (the “PIPE”) with Nextech to sell an aggregate of 2.5 million shares of common stock at a price per share of $12.00, a premium to the closing price on January 5, 2024, that is expected to result in gross proceeds of $30.0 million.
Related news for (RLAY)
- MoBot’s Stock Market Highlights – 09/26/25 07:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 09/26/25 06:00 PM
- MoBot alert highlights: NASDAQ: YHC, NASDAQ: JFB, NASDAQ: RLAY, NASDAQ: APDN, NASDAQ: OSRH (09/26/25 05:00 PM)
- Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
- Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025